The Pennant Group (NASDAQ:PNTG) Issues FY 2024 Earnings Guidance

The Pennant Group (NASDAQ:PNTG) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 0.900-0.960 for the period, compared to the consensus EPS estimate of 0.910. The company issued revenue guidance of $665.3 million-$706.5 million, compared to the consensus revenue estimate of $679.3 million.

The Pennant Group Price Performance

Shares of NASDAQ PNTG traded up $1.42 during trading on Friday, reaching $33.42. The company had a trading volume of 262,213 shares, compared to its average volume of 198,817. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.48. The Pennant Group has a twelve month low of $11.95 and a twelve month high of $37.13. The stock has a 50-day moving average price of $33.80 and a two-hundred day moving average price of $28.37. The stock has a market capitalization of $1.01 billion, a PE ratio of 49.15, a price-to-earnings-growth ratio of 3.41 and a beta of 2.02.

The Pennant Group (NASDAQ:PNTG) last announced its earnings results on Tuesday, August 6th. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.02. The firm had revenue of $168.75 million during the quarter, compared to the consensus estimate of $156.71 million. The Pennant Group had a net margin of 3.24% and a return on equity of 14.02%. As a group, sell-side analysts predict that The Pennant Group will post 0.75 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on PNTG shares. Oppenheimer boosted their price objective on shares of The Pennant Group from $34.00 to $37.00 and gave the company an “outperform” rating in a research report on Friday. Truist Financial boosted their price target on The Pennant Group from $34.00 to $38.00 and gave the company a “hold” rating in a report on Monday, October 7th. Stephens reissued an “overweight” rating and set a $40.00 price target on shares of The Pennant Group in a research note on Wednesday, October 9th. Finally, Royal Bank of Canada lifted their price objective on The Pennant Group from $26.00 to $38.00 and gave the company an “outperform” rating in a research report on Wednesday, October 23rd.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.